These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17964527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC, Bennett RG, Hamel FG.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):390-4. PubMed ID: 9514933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin-degrading enzyme.
    Authier F, Posner BI, Bergeron JJ.
    Clin Invest Med; 1996 Jun 17; 19(3):149-60. PubMed ID: 8724818
    [Abstract] [Full Text] [Related]

  • 6. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA, George AM, Eisenhauer PB, Conn K, Gao W, Carreras I, Wells JM, McKee A, Ullman MD, Fine RE.
    J Neurosci Res; 2006 May 15; 83(7):1262-70. PubMed ID: 16511862
    [Abstract] [Full Text] [Related]

  • 7. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
    Bernstein HG, Ernst T, Lendeckel U, Bukowska A, Ansorge S, Stauch R, Have ST, Steiner J, Dobrowolny H, Bogerts B.
    J Psychiatr Res; 2009 Sep 15; 43(13):1095-105. PubMed ID: 19394958
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
    Li CZ, Zhang SH, Shu CD, Ren W.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb 15; 22(2):151-4. PubMed ID: 12390813
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical demonstration of the zinc metalloprotease insulin-degrading enzyme in normal and malignant human breast: correlation with tissue insulin levels.
    Radulescu RT, Hufnagel C, Luppa P, Hellebrand H, Kuo WL, Rosner MR, Harbeck N, Giersig C, Meindl A, Schmitt M, Weirich G.
    Int J Oncol; 2007 Jan 15; 30(1):73-80. PubMed ID: 17143514
    [Abstract] [Full Text] [Related]

  • 10. Microarray analysis of insulin-regulated gene expression in the liver: the use of transgenic mice co-expressing insulin-siRNA and human IDE as an animal model.
    Jee S, Hwang D, Seo S, Kim Y, Kim C, Kim B, Shim S, Lee S, Sin J, Bae C, Lee B, Jang M, Kim M, Yim S, Jang I, Cho J, Chae K.
    Int J Mol Med; 2007 Dec 15; 20(6):829-35. PubMed ID: 17982690
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
    Harada S, Smith RM, Hu DQ, Jarett L.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):154-8. PubMed ID: 8573122
    [Abstract] [Full Text] [Related]

  • 12. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
    Liu JP, Yuan SZ, Zhang SN.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 16; 87(38):2719-23. PubMed ID: 18167254
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of inhibition of ANG-2 expression in Ishikawa cell line].
    Zhou HJ, He RR, Xia BM, Xun QY, Pan JS, Hu YL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun 16; 26(3):249-53. PubMed ID: 19504433
    [Abstract] [Full Text] [Related]

  • 16. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
    Kuo WL, Gehm BD, Rosner MR.
    Mol Endocrinol; 1991 Oct 16; 5(10):1467-76. PubMed ID: 1775131
    [Abstract] [Full Text] [Related]

  • 17. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G, Rizzarelli E, Spoto G.
    J Mass Spectrom; 2009 May 16; 44(5):735-41. PubMed ID: 19127548
    [Abstract] [Full Text] [Related]

  • 18. Retinoblastoma protein co-purifies with proteasomal insulin-degrading enzyme: implications for cell proliferation control.
    Radulescu RT, Duckworth WC, Levy JL, Fawcett J.
    Biochem Biophys Res Commun; 2010 Apr 30; 395(2):196-9. PubMed ID: 20362553
    [Abstract] [Full Text] [Related]

  • 19. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
    Vandenbroucke RE, De Geest BG, Bonné S, Vinken M, Van Haecke T, Heimberg H, Wagner E, Rogiers V, De Smedt SC, Demeester J, Sanders NN.
    J Gene Med; 2008 Jul 30; 10(7):783-94. PubMed ID: 18470950
    [Abstract] [Full Text] [Related]

  • 20. ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons.
    Du J, Chang J, Guo S, Zhang Q, Wang Z.
    Neurosci Lett; 2009 Oct 23; 464(2):140-5. PubMed ID: 19616072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.